Literature DB >> 7067095

Rapid method for eliminating labile glycosylated hemoglobin from the assay for hemoglobin A1.

D M Nathan, E Avezzano, J L Palmer.   

Abstract

The irreversible formation of stable glycosylated hemoglobin proceeds through a labile intermediate that is indistinguishable, by most methods, from the stable glycosylated product. The inclusion of the labile intermediate, which changes acutely with acute blood glucose changes, detracts from the utility of the assay as an index of chronic glucose concentration. We have developed a rapid, reliable chemical method for eliminating the labile intermediate: a 30-min incubation of whole-blood samples with semi-carbazide (30 mmol/L) and aniline (12 mmol/L) at pH 5 and 38 degrees C. The semicarbazide serves as a glucose trap; the transfer of glucose from the labile glycosylated hemoglobin to the semicarbazide is catalyzed by the acidic pH and aniline. This treatment is effective in the three most commonly used assays: "high-performance" liquid chromatography, electrophoresis, and a minicolumn kit.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7067095

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Analytical evaluation of the ADAMS A1c HA8180T analyzer for the measurement of HbA1c.

Authors:  Eloísa Urrechaga
Journal:  J Clin Lab Anal       Date:  2017-02-25       Impact factor: 2.352

2.  Effects of biosynthetic human proinsulin on plasma lipids in type 2 diabetes mellitus.

Authors:  H Drexel; T Hopferwieser; H Braunsteiner; J R Patsch
Journal:  Klin Wochenschr       Date:  1988-12-01

Review 3.  Glycosylated haemoglobin: measurement and clinical use.

Authors:  I Peacock
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

4.  Long-term effect of intensified insulin treatment on lipid parameters in diabetes mellitus type I.

Authors:  A Dzien; M Lechleitner; T Hopferwieser; H Drexel; J R Patsch; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1991-08-01

5.  Serum fructosamine and glycated haemoglobin measurements in diabetic control.

Authors:  E J Hindle; G M Rostron; S A Clark; J A Gatt
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

6.  Elevated long-term glycated haemoglobin precedes proliferative retinopathy and nephropathy in type 1 (insulin-dependent) diabetic patients.

Authors:  C E Kullberg; H J Arnqvist
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.